The role of antibiotic and probiotic therapies in current and future management of inflammatory Bowel disease
โ Scribed by Julia B. Ewaschuk; Qassim Z. Tejpar; Isaac Soo; Karen L. Madsen; Richard N. Fedorak
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 171 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1522-8037
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The inflammatory bowel diseases (IBD), notably Crohn's disease (CD) and ulcerative colitis (UC), are systemic inflammatory diseases primarily involving the gastrointestinal tract. Twenty percent to 40% of patients with IBD develop extraintestinal inflammation and symptoms, known as extraintestinal m
The inflammatory bowel diseases (IBDs) are a group of heterogeneous disorders characterized by acute and chronic inflammatory changes in the small or large bowel, or in both. Increasing incidence and prevalence figures for IBD both in the developed and developing world indicate that environmental fa